What powers jto.org?

Last seen Jun 2026 · 17 technologies across 12 categories

Advertising

Google Publisher Tag

since Feb 2021

CDN

Cloudflare

since Jan 2021

Cookie compliance

OneTrust

since Apr 2021

Digital asset management

Frontify

since Jan 2025

Font scripts

Google Font API

since Jul 2020

JavaScript libraries

jQuery v3.7.1

since Jun 2018

jQuery UI v1.10.2

since Jul 2020

Miscellaneous

HTTP/3

since Sep 2022

Webpack

since Oct 2025

Programming languages

Java

since Sep 2021

RUM

Cloudflare Browser Insights

since Jun 2021

New Relic

since Jul 2021

Security

Cloudflare Bot Management

since Nov 2021

HSTS

since Sep 2022

reCAPTCHA

since Oct 2025

Tag managers

Google Tag Manager

since Jun 2018

Video players

YouTube

since Aug 2022

Top search keywords

Keyword	Position	Est. monthly visits
ggo	#8	440
receiver operating characteristic	#14	340
tacti	#8	290
ras/mapk signaling pathway	#1	270
hazard ratio	#5	250
ras/mapk pathway	#1	200
superior vena cava syndrome	#12	170
receiver operating characteristic curve	#10	170
endothelial growth factor	#8	130
ras signaling pathway	#1	120
ras signaling cascade	#1	120
trapped lung	#4	110
thoracic	#84	100
vegf	#9	99
art1	#9	99
jto impact factor	#1	97
lung cancer rates in japan	#1	97
hazard ratio interpretation	#3	97
journal of thoracic oncology	#1	90
mediastinal lymphadenopathy	#12	74
kras g12c inhibitor	#2	72
lusc	#13	72
thymoma	#27	57
thymoma	#27	57
iaslc	#3	53

The site's top keywords in Google (US), with the visits each one is estimated to bring per month.

Top backlinks

From	Anchor text
microsoft.com	View Publication
weforum.org	five-year survival rate is low at 7.5% and 6.3%, respectively
nationalgeographic.com	studies
frontiersin.org	https://www.jto.org/article/S1556-0864(23)02310-9/fulltext
lemonde.fr	Bronchogenic carcinoma after lung transplantation: characteristics and outcomes
birmingham.ac.uk	https://www.jto.org/article/S1556-0864(19)30743-9/abstract
mayoclinic.org	Evaluating cryoablation of metastatic lung tumors in patients — Safety and
healthline.com	recent study
financialexpress.com	Journal of Thoracic Oncology
webmd.com	Journal of Thoracic Oncology
mdpi.com	Green Version
livescience.com	only some countries
elsevier.com	Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Mult
medicalnewstoday.com	2018 study
medscape.com	updated data
corriere.it	un nuovo studio appena pubblicato sul Journal of Thoracic Oncology
startribune.com	study authors wrote
azcentral.com	study
singlecare.com	Journal of Thoracic Oncology
politico.eu	2016 study
derstandard.at	Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune
imperial.ac.uk	Publisher Web Link
cancer.gov	Current and Future Management of Malignant Mesothelioma..
elconfidencial.com	[enlace]
health.com	2017 review

Top links pointing at the site, one per source domain, strongest first. The anchor text opens the page carrying the link.

Audience

74% desktop
24% phone
2% tablet

United States
India
Japan
United Kingdom
France
Italy

Countries where the site has Chrome traffic, strongest markets first.

Open Page Rank

6.49 / 10 · ranked #76,395 of all domains

472 referring domains · OpenPageRank

Search traffic

8,700 est. monthly organic visits (US)

5,860 keywords in Google's top 30

Core Web Vitals

LCP	5.2 s
INP	150 ms
CLS	0.15
TTFB	2700 ms

Real user p75, Chrome UX Report, Jun 2026.

Recent changes

detected Webpack May 2026
dropped Webpack Apr 2026
detected Google Publisher Tag Oct 2025
detected Google Tag Manager Oct 2025
detected reCAPTCHA Oct 2025
detected Webpack Oct 2025